These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 6166139)

  • 1. [Serologic results of the evaluation of specific meningococcal donor gamma-globulin].
    Sharav Ch; Gombozhav NA; Semina NP; Deviatkina NP; Petrova IS
    Zh Mikrobiol Epidemiol Immunobiol; 1981 Mar; (3):95. PubMed ID: 6166139
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation of the prophylactic effect of gamma globulin in meningococcal infection.
    Pokrovskii VI; Demina AA; Cend N; Devyatkina NV; Zhamba G; Semina NA; Ochirvaan G; Ceren S
    J Hyg Epidemiol Microbiol Immunol; 1978; 22(2):230-6. PubMed ID: 84840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antibody titer against B-streptococci in human gamma globulin].
    Fox EN; Schmidt BL; Collins MS
    MMW Munch Med Wochenschr; 1981 Nov; 123(46):1743-4. PubMed ID: 6171730
    [No Abstract]   [Full Text] [Related]  

  • 4. [Evaluation of the effectiveness of gamma-globulin for prevention of meningococcal infections in children's pre-school collectives (preliminary report)].
    Favorova LA; Chernyshova TF; Sokova IN; Khrometskaia TM; Teleshevskaia EA
    Zh Mikrobiol Epidemiol Immunobiol; 1973 Jan; 50(1):22-5. PubMed ID: 4130945
    [No Abstract]   [Full Text] [Related]  

  • 5. [Serologic evaluation of the efficiency of meningococcal capsular polysaccharide vaccines of serogroups A and C: correlation with age, dosage, previous immune status and serological assays].
    Veronesi R; Fayet MT; Stellmann C; Takeda AK; Feldman C; Focaccia R; Mazza CC; Oliveira CE; Sebe E; Adelino M; Diniz JM; Zuccas WA
    Rev Hosp Clin Fac Med Sao Paulo; 1977; 32(5):296-305. PubMed ID: 392678
    [No Abstract]   [Full Text] [Related]  

  • 6. The failure of gamma globulin as a prophylactic agent in meningococcal disease.
    Sample DW; Gauld JR; Warram JH; Winter PE; Runcik K; Gauld RL
    Am J Epidemiol; 1966 Jul; 84(1):156-62. PubMed ID: 4161457
    [No Abstract]   [Full Text] [Related]  

  • 7. [Tests of anti-meningococcal vaccination with A and C group polysaccharide vaccines].
    Galli MG; Fara GM; Saletti M; Porro M; Ribero ML
    Ann Sclavo; 1981; 23(3):356-66. PubMed ID: 6803687
    [No Abstract]   [Full Text] [Related]  

  • 8. [The concentration of antibodies to several exoenzymes of beta-hemolytic streptococci in commercial preparations of gamma globulin].
    Khovanova AM; Venediktova NIa; Zadoia IuN; Kolpakova VE
    Zh Mikrobiol Epidemiol Immunobiol; 1976 May; (5):133-6. PubMed ID: 60017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Results of a controlled epidemiological trial of the application of placental gamma globulin in foci of meningococcal infection].
    Favorova LA; Sokova IN; Chernyshova TF; Khrometskaia TM; Teleshevskaia EA
    Zh Mikrobiol Epidemiol Immunobiol; 1975 Jun; (6):15-8. PubMed ID: 50681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The immunological responses observed in field studies in Africa with group A meningococcal vaccines.
    Gotschlich EC; Rey M; Etienne J; Sanborn WR; Triau R; Cvjetanović B
    Prog Immunobiol Stand; 1971; 5():485-91. PubMed ID: 4633975
    [No Abstract]   [Full Text] [Related]  

  • 11. [Comparative study of the antibody concentration and protective activity against Pseudomonas aeruginosa of gamma-globulin and IgM-enriched immunoglobulin preparations].
    Kiseleva IA; Kandiurina VG; Timofeeva GV
    Zh Mikrobiol Epidemiol Immunobiol; 1986 Apr; (4):68-71. PubMed ID: 2424197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meningococcal group B vaccine trial in Norway 1981--1982. Preliminary report of results available November 1982.
    Frøholm LO; Berdal BP; Bøvre K; Gaustad P; Harboe A; Holten E; Høiby EA; Lystad A; Omland T; Frasch CE
    NIPH Ann; 1983 Dec; 6(2):133-8. PubMed ID: 6427703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IgG antibodies in intravenous gammaglobulins.
    Lever AM; Webster AD
    Lancet; 1987 Jan; 1(8524):99. PubMed ID: 2432369
    [No Abstract]   [Full Text] [Related]  

  • 14. Meningococcal serogroup a avidity indices as a surrogate marker of priming for the induction of immunologic memory after vaccination with a meningococcal A/C conjugate vaccine in infants in the United Kingdom.
    Joseph H; Miller E; Dawson M; Andrews N; Feavers I; Borrow R
    J Infect Dis; 2001 Sep; 184(5):661-2. PubMed ID: 11494176
    [No Abstract]   [Full Text] [Related]  

  • 15. [Antimeningococcal vaccination in member States of the Organization for Coordination and Cooperation in the Control of Major Epidemics].
    Etienne J
    Prog Immunobiol Stand; 1971; 5():492-6. PubMed ID: 4633976
    [No Abstract]   [Full Text] [Related]  

  • 16. [Anti-verotoxin-neutralizing antibody in intravenous gammaglobulin preparations].
    Adachi E; Yoshino K; Kimura T; Matsumoto Y; Takeda T
    Kansenshogaku Zasshi; 1998 Aug; 72(8):808-12. PubMed ID: 9780583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparative evaluation of the methods of monitoring the activity of diagnostic meningococcal group-specific sera].
    Ereshchenko VV; Petrova ZS; Zhukova LF
    Lab Delo; 1982; (9):567-9. PubMed ID: 6183530
    [No Abstract]   [Full Text] [Related]  

  • 18. The duration of the antibody response to meningococcal vaccination in an African village.
    Greenwood BM; Whittle HC; Bradley AK; Fayet MT; Gilles HM
    Trans R Soc Trop Med Hyg; 1980; 74(6):756-60. PubMed ID: 6782720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibodies to meningococcus polysaccharides in nonspecific gamma-globulins from different regions of the world.
    Demina AA; Samsonova IM; Fayet MT; Béranger J; Gibilin N; Plan R; Triau R
    J Hyg Epidemiol Microbiol Immunol; 1983; 27(4):437-44. PubMed ID: 6198376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity and immunological priming of the serogroup a portion of a bivalent meningococcal A/C conjugate vaccine in 2-year-old children.
    Joseph H; Ryall R; Bybel M; Papa T; MacLennan J; Buttery J; Borrow R
    J Infect Dis; 2003 Apr; 187(7):1142-6. PubMed ID: 12660929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.